For the Media
Dr. Denise Galloway is the associate director of the Human Biology Division and a member of the Public Health Sciences Division. She is also director of Fred Hutch's Pathogen-Associated Malignancies Integrated Research Center. Early in her career, Dr. Galloway became fascinated by the idea that a virus could lead to cancer by sparking changes within cells. This idea led her to study the human papilloma virus (HPV) and to make breakthrough contributions to a vaccine that prevents HPV and averts tens of thousands of cervical cancer cases each year.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.